The Octahydroindene Carboxyl Substructure from Dihydrobetulinic Acid is Essential to Inhibit Topoisomerase IB from Leishmania donovani
AUTOR(ES)
Rocha, Camila A., Sanches, Paulo R. S., Marchetto, Reinaldo, Zottis, Aderson
FONTE
J. Braz. Chem. Soc.
DATA DE PUBLICAÇÃO
2016-03
RESUMO
The dihydrobetulinic acid is a known competitive inhibitor of topoisomerase IB from Leishmania donovani, a validated target for developing new antileishmanial drugs. However, its binding mode and interaction pocket have not been established yet. We combined docking and molecular dynamics simulations to identify the most probable binding pocket. Our best model strongly suggests a cavity involving the residues arginine 314 and arginine 410 from chain A, and the catalytic tyrosine 222 from chain B as the interaction site and a substructure of this terpene inhibitor as essential for the process of molecular recognition. Then, a new class of inhibitors with increased affinity could be designed by structure-based approaches.
Documentos Relacionados
- Characterization of a Leishmania donovani gene encoding a protein that closely resembles a type IB topoisomerase.
- Characterization of the ATPase activity of topoisomerase II from Leishmania donovani and identification of residues conferring resistance to etoposide
- Functional dissection of the C-terminal domain of type II DNA topoisomerase from the kinetoplastid hemoflagellate Leishmania donovani
- An insight into the active site of a type I DNA topoisomerase from the kinetoplastid protozoan Leishmania donovani
- Characterisation of the gene encoding type II DNA topoisomerase from Leishmania donovani: a key molecular target in antileishmanial therapy
